TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Κύριος συγγραφέας: | Afroza, Halima |
---|---|
Άλλοι συγγραφείς: | Talukder, Mesbah |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2024
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/22075 |
Παρόμοια τεκμήρια
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
ανά: Islam, Nahidul
Έκδοση: (2023) -
Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
ανά: Tamanna, Shams Tahsin
Έκδοση: (2020) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
ανά: Islam, S.M. Zahidul
Έκδοση: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
ανά: Khandker, Tahia Anjum
Έκδοση: (2024) -
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
ανά: Akter, Anika
Έκδοση: (2022)